← All diseases
Heart and blood vessels
Cardiac amyloidosis
Would you like to receive a message when there is new research about cardiac amyloidosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was investigated — and you'll receive a notification as soon as new research on Cardiac Amyloidosis is available. View what Premium costs.
Publications and studies (1416)
- Limited duration of dexamethasone in newly diagnosed AL amyloidosis: impact on response, toxicity, and survival. (2026/12/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Septal thickness to QRS voltage ratio in Lead I/aVR: A simple tool for estimating cardiac amyloid burden. (2026/10/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Amyloid-Like Immunoglobulin Deposition Neuropathy. (2026/09/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Vitronectin-driven amyloid deposition disrupts mitochondrial homeostasis via integrin-mediated pathway in a humanized mouse model of transthyretin cardiac amyloidosis. (2026/08/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Transthyretin Amyloid Cardiomyopathy in Women: Epidemiology, Diagnostic Delay, and Clinical Implications. (2026/08/10) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. False-negative 99mTc-PYP bone scintigraphy in early cardiac amyloidosis: a rapidly progressive case in a young woman. (2026/08/07) ♡
- Outcomes of living related kidney donors of recipients with familial mediterranean fever-associated Amyloid A Amyloidosis. (2026/08/07) ♡
- Analysis of serum NMR metabolomics in fibrotic diseases of the myocardium. (2026/08/07) ♡
- Utility of Prognostic Staging Systems in Transthyretin Amyloidosis Cardiomyopathy in the Era of Available Disease-Modifying Treatment. (2026/08/07) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cardiac Tamponade From Lymphocytic Constrictive Pericarditis in Primary AL Amyloidosis Without Myocardial Involvement. (2026/08/06) ♡
- Arterial-myocardial coupling in primary light chain amyloidosis: A prospective observational study of vascular involvement. (2026/08/06) ♡
- Comorbidity Burden in Transthyretin Amyloidosis With Cardiomyopathy: Insights From the HELIOS-B Trial. (2026/08/06) ♡
- Effect of acoramidis on risk of death and heart problem-related hospitalizations in people with transthyretin amyloid cardiomyopathy: a plain language summary. (2026/08/05) ♡
- Health Care Resource Utilization in Transthyretin Amyloid Cardiomyopathy Compared With Non-amyloid Heart Failure and the General Population. (2026/08/04) ♡
- Temporal shifts in diagnostic testing for cardiac amyloidosis across U.S. health systems. (2026/08/03) ♡
- Role of FibroScan in evaluating hepatic involvement in systemic amyloidosis: a single-centre prospective pilot study. (2026/08/03) ♡
- Prevalence and Determinants of Asymmetric Septal Hypertrophy (ASH) in Diseases of Left Ventricular Hypertrophy (LVH). (2026/08/03) ♡
- Plain language summary of how acoramidis affects the total number of heart problems over time in people with ATTR-CM: findings from the ATTRibute-CM study. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiovascular Care in Multiple Myeloma: A Comprehensive Review and Integrated Systems-Based Approach from a UK Cardio-Oncology Centre of Excellence. (2026/08/03) ♡
- Triple amyloidosis involving fibrinogen Aα-chain, apolipoprotein A-I and EGF-containing fibulin-like matrix protein 1 in an aged dog. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Efficacy and tolerability of sodium-glucose cotransporter-2 inhibitors in transthyretin amyloid cardiomyopathy: A systematic review and stratified meta-analysis. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Atrial Fibrillation in Transthyretin Amyloid Cardiomyopathy: Mechanisms, Prognostic Implications, and Management. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Laboratory investigations to rule out AL amyloidosis: practical guidance for the cardiologist]. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multidimensional care in transthyretin cardiac amyloidosis: Integrating extracardiac organ involvement and comorbidity management. (2026/08/01) ♡
- Human islet amyloid polypeptide aggregation upregulates the mitochondrial cholesterol transport protein StAR and induces mitochondrial dysfunction in beta cells. (2026/08/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Cardiac Amyloidosis in Asia: What We Know and Don't Know. (2026/08/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Diagnosing Transthyretin Cardiac Amyloidosis in Japan: Lessons From J-COSSA on Access, Equity, and Earlier Detection. (2026/08/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Beyond Wall Thickness: Phenotype-Guided Diagnosis of Left Ventricular Hypertrophy. (2026/08/01) ♡
- Rationale and Design of ACO-REAL: A Real-World Non-Interventional Study of Acoramidis in Routine Clinical Practice. (2026/07/31) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Wild-Type Transthyretin Amyloid Cardiomyopathy With Positive (18)F-FDG/(13)N-Ammonia Cardiac Positron Emission Tomography. (2026/07/31) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Myocardial remodeling in valvular heart disease: pathophysiology, multimodality imaging and treatment implications. (2026/07/30) ♡
- A rigorous standardized uptake value-based framework for monitoring tafamidis response in transthyretin cardiac amyloidosis with bone-avid single-photon emission computed tomography/computed tomography. (2026/07/30) ♡
- Diagnostic utility of deep excisional skin biopsy including abdominal fat for transthyretin cardiac amyloidosis. (2026/07/30) ♡
- Contemporary Real-World Treatment of Cardiac Transthyretin Amyloidosis with Tafamidis: A Long-Term Multicentre Study. (2026/07/30) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Anakinra for intravenous immunoglobulin-resistant Kawasaki disease: a systematic literature review. (2026/07/30) ♡
- The severity of harm score database: an evidence-based foundation for laboratory test risk analysis. (2026/07/29) ♡
- Effect of Acoramidis on Heart Failure-Related Health Status: A Secondary Analysis of the ATTRibute-CM Randomized Clinical Trial. (2026/07/29) ♡
- Sex Differences in Presentation and Outcomes of Transthyretin Amyloid Cardiomyopathy. (2026/07/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Transjugular Tricuspid Valve Edge-to-Edge Repair. (2026/07/25) ♡
- Sex Differences in Phenotype and Tafamidis-Associated Survival in Val122Ile Transthyretin Cardiac Amyloidosis. (2026/07/25) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. AL Cardiac Amyloidosis in Resource-Limited Settings: Diagnostic Challenges and Therapeutic Gaps. (2026/07/25) ♡
- Pathology-Based Validation of Quantitative SPECT/CT in Patients With Suspected Transthyretin Amyloid Cardiomyopathy. (2026/07/23) ♡
- A novel method to classify exercise response in patients with cardiac amyloidosis - The RoMa classification. (2026/07/23) ♡
- Cardiovascular Imaging with Total Body PET. (2026/07/23) ♡
- High CA125 levels as a red flag for ATTR Cardiac Amyloidosis. (2026/07/22) ♡
- Automated identification of cardiac amyloidosis using cross-modal neural networks on [Formula: see text]-Pyrophosphate SPECT imaging and clinical data. (2026/07/22) ♡
- Delayed Diagnosis of Transthyretin Cardiac Amyloidosis Is Associated With Heart Failure Hospitalizations and Mortality. (2026/07/22) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. From diagnosis to quantification of amyloid burden: Reappraising the wall thickness-to-voltage ratio in cardiac amyloidosis. (2026/07/22) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Five-year follow-up of leptomeningeal transthyretin amyloidosis (Ala45Thr) with CNS involvement under tolcapone therapy. (2026/07/22) ♡
- Identifying implementation strategies to increase the early detection of cardiac amyloidosis: a pre-implementation study. (2026/07/22) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.